Light-Activated Wound Patch Developed for Targeted Drug Delivery

Researchers at the Swiss materials research institute Empa have developed a light-responsive material aimed at improving wound dressings. This innovation allows for the precise delivery of antiseptics and other therapeutic agents, which could significantly benefit patients with chronic wounds, particularly those with diabetes.

The technology utilizes nanoparticles coated with a light-sensitive polymer that releases active ingredients when exposed to visible LED light. The release can be halted by switching off the light, enabling controlled timing and dosage of treatment.

Led by Luciano Boesel and Giorgia Giovannini, the team has created a system using silica nanoparticles loaded with chlorhexidine, a common wound antiseptic. The polymer coating around the nanoparticles changes structure when exposed to specific light wavelengths, allowing for the controlled release of the disinfectant.

Future developments may include integrating this material with sensors that monitor bacterial activity in wounds, potentially allowing for real-time adjustments in treatment. While the light-responsive dressings may have higher manufacturing costs, they could reduce the need for frequent dressing changes and hospital visits, ultimately offsetting these expenses.